Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination-Reference-Cited by-同舟云学术

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination

Published:2022-04 Issue:15 Volume:40 Page:2274-2281
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Morga Antonia,Kimura Tomomi,Feng Qi,Rozario Nigel,Schwartz Jason

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP);MMWR Morb Mortal Wkly Rep,2012

2. Aging population and future burden of pneumococcal pneumonia in the United States;Wroe;J Infect Dis,2012

3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: Updated recommendations of the Advisory Committee on Immunization Practices;Matanock;MMWR Morb Mortal Wkly Rep,2019

4. Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States;Talbird;Hum Vaccin Immunother,2021

5. Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study;Zhang;BMC Infect Dis,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the Population Newly Eligible for the Pneumococcal Conjugate Vaccine;American Journal of Preventive Medicine;2024-01

2. Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany;Expert Review of Vaccines;2023-10-27

3. Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain;Vaccine;2023-08

4. Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany;2023-02-17

5. The role of a single-shot higher-valency pneumococcal vaccine in overcoming challenges regarding invasive pneumococcal disease in Hong Kong;Hong Kong Medical Journal;2023-02-08